Hongxia Lin

722 total citations
28 papers, 559 citations indexed

About

Hongxia Lin is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Hongxia Lin has authored 28 papers receiving a total of 559 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 12 papers in Oncology and 9 papers in Cancer Research. Recurrent topics in Hongxia Lin's work include Cancer-related Molecular Pathways (5 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Parasitic Diseases Research and Treatment (2 papers). Hongxia Lin is often cited by papers focused on Cancer-related Molecular Pathways (5 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Parasitic Diseases Research and Treatment (2 papers). Hongxia Lin collaborates with scholars based in United States, China and Netherlands. Hongxia Lin's co-authors include Murugesan Gounder, Mark N. Stein, Susan Goodin, Robert S. DiPaola, Eileen White, Kevin Bray, Chandrika Jeyamohan, Simantini Eddy, Dmitri Dvorzhinski and Joseph R. Bertino and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Hongxia Lin

28 papers receiving 552 citations

Peers

Countries citing papers authored by Hongxia Lin

Since Specialization

Citations

This map shows the geographic impact of Hongxia Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongxia Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongxia Lin more than expected).

Fields of papers citing papers by Hongxia Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongxia Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongxia Lin. The network helps show where Hongxia Lin may publish in the future.

Co-authorship network of co-authors of Hongxia Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Hongxia Lin. A scholar is included among the top collaborators of Hongxia Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongxia Lin. Hongxia Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Catalytic performance and mechanism of toluene oxidation in high humidity over the mesoporous titania-ceria-supported Pt or Pd catalysts 2025 ·Applied Catalysis A General ·Fuping Xu, Jia Wang, Yutong Zhao, Hongxia Lin, Hongxia Chen, Yi Zhang, Xuefeng Wei, (unknown)	4
2	Phytohormones involved in vascular cambium activity in woods: current progress and future challenges 2024 ·Frontiers in Plant Science ·(unknown), (unknown), (unknown), Xiaoxu Li, Yuqian Zhang, Hongxia Lin, Yang Li, Z. Ma, Jianwei Han, (unknown), Minjie Wu, (unknown), Jinxing Lin, Yuanyuan Zhao	2
3	MicroRNA257 promotes secondary growth in hybrid poplar 2024 ·Plant Physiology and Biochemistry ·Yayu Guo, (unknown), Hou‐Ling Wang, Hongxia Lin, (unknown), Yuanyuan Zhao	1
4	A phase I trial of riluzole and sorafenib in patients with advanced solid tumors: CTEP #8850 2023 ·Oncotarget ·Kristen Spencer, (unknown), Joseph Aisner, Mark N. Stein, Jyoti Malhotra, Weichung Shih, Nancy Chan, Ann W. Silk, Shridar Ganesan, Susan Goodin, Murugesan Gounder, Hongxia Lin, Jiadong Li, (unknown), (unknown), Suzie Chen, Janice M. Mehnert	5
5	Potential value of tumor stiffness and sE-cadherin in predicting the response to neoadjuvant therapy in HER2-positive breast cancers 2022 ·Future Oncology ·(unknown), (unknown), Hongxia Lin, Wanjun Chen, (unknown), (unknown), Yaling Chen, (unknown)	2
6	The Angiotensin-Converting Enzyme Inhibitory State Promotes the Transformation of Non-Small Cell Lung Cancer Blood Supply Pattern Toward Vasculogenic Mimicry Formation 2021 ·Frontiers in Oncology ·(unknown), (unknown), (unknown), Hong Ye, Hongxia Lin, Lei Ni	11
7	A phase I study of veliparib with cyclophosphamide and veliparib combined with doxorubicin and cyclophosphamide in advanced malignancies 2021 ·Cancer Chemotherapy and Pharmacology ·Antoinette R. Tan, Nancy Chan, Brian F. Kiesel, Mark N. Stein, Rebecca A. Moss, Jyoti Malhotra, Joseph Aisner, Mansi Shah, Murugesan Gounder, Hongxia Lin, Michael P. Kane, Yong Lin, Jiuping Ji, Alice P. Chen, Jan H. Beumer, Janice M. Mehnert	2
8	A Novel Antibody-Toxin Conjugate to Treat Mantle Cell Lymphoma 2019 ·Frontiers in Oncology ·Gulam M. Rather, Siang-Yo Lin, Hongxia Lin, Zoltán Székely, Joseph R. Bertino	4
9	A phase I trial of MK-2206 and hydroxychloroquine in patients with advanced solid tumors 2019 ·Cancer Chemotherapy and Pharmacology ·Janice M. Mehnert, (unknown), Jyoti Malhotra, Kristen Spencer, (unknown), Susan Goodin, Antoinette R. Tan, Joseph Aisner, Rebecca A. Moss, Hongxia Lin, Joseph R. Bertino, Darlene Gibbon, L. Austin Doyle, Eileen White, Mark N. Stein	25
10	A phase I study of AT-101, a BH3 mimetic, in combination with paclitaxel and carboplatin in solid tumors 2019 ·Investigational New Drugs ·Mark N. Stein, Susan Goodin, (unknown), Darlene Gibbon, Rebecca A. Moss, (unknown), (unknown), Yujie Zhao, Naoko Takebe, Antoinette R. Tan, Joseph Aisner, Hongxia Lin, Neal Ready, Janice M. Mehnert	22
11	Zinc Metallochaperones Reactivate Mutant p53 Using an ON/OFF Switch Mechanism: A New Paradigm in Cancer Therapeutics 2018 ·Clinical Cancer Research ·Xin Yu, Samuel Kogan, Ying Chen, (unknown), (unknown), Hongxia Lin, John Gilleran, Brian Buckley, Dirk F. Moore, Joseph Bertino, Chang Chan, S. David Kimball, Stewart N. Loh, Darren R. Carpizo	33
12	Cefoxitin Plasma and Subcutaneous Adipose Tissue Concentration in Patients Undergoing Sleeve Gastrectomy 2015 ·Clinical Therapeutics ·Luigi Brunetti, Leonid Kagan, (unknown), Lauren M. Aleksunes, Hongxia Lin, Steven Buyske, Ronald Nahass	11
13	Quantification of folate metabolism using transient metabolic flux analysis 2015 ·Cancer & Metabolism ·Philip M. Tedeschi, Nadine Johnson-Farley, Hongxia Lin, Laura M. Shelton, Takushi Ooga, Gillian Mackay, Niels van den Broek, Joseph R. Bertino, Alexei Vázquez	20
14	A sensitive liquid chromatography–mass spectrometry bioanalytical assay for a novel anticancer candidate – ZMC1 2015 ·Biomedical Chromatography ·Hongxia Lin, Xin Yu, Oliver S. Eng, Brian Buckley, Ah‐Ng Tony Kong, Joseph R. Bertino, Darren R. Carpizo, Murugesan Gounder	4
15	Suppression of Cytosolic NADPH Pool by Thionicotinamide Increases Oxidative Stress and Synergizes with Chemotherapy 2015 ·Molecular Pharmacology ·Philip M. Tedeschi, Hongxia Lin, Murugesan Gounder, John E. Kerrigan, Emine Ercikan Abali, Kathleen W. Scotto, Joseph R. Bertino	35
16	Assessment of γH2AX levels in circulating tumor cells in patients treated with veliparib in combination with doxorubicin and cyclophosphamide in metastatic breast cancer. 2013 ·Journal of Clinical Oncology ·Antoinette R. Tan, Deborah Toppmeyer, Serena Wong, Hongxia Lin, Murugesan Gounder, Rebecca A. Moss, Mark N. Stein, Janice M. Mehnert, Sinae Kim, Alice P. Chen, Robert S. DiPaola	2
17	A validated HPLC assay for the determination of R-(−)-gossypol in human plasma and its application in clinical pharmacokinetic studies 2012 ·Journal of Pharmaceutical and Biomedical Analysis ·Hongxia Lin, Murugesan Gounder, Joseph R. Bertino, Ah‐Ng Tony Kong, Robert S. DiPaola, Mark N. Stein	9
18	A second target of benzamide riboside 2012 ·Cancer Biology & Therapy ·Breton Roussel, Nadine Johnson-Farley, John E. Kerrigan, Kathleen W. Scotto, Debabrata Banerjee, Krzysztof Felczak, Krzysztof W. Pankiewicz, Murugesan Gounder, Hongxia Lin, Emine Ercikan Abali, Joseph R. Bertino	10
19	Targeting tumor metabolism with 2‐deoxyglucose in patients with castrate‐resistant prostate cancer and advanced malignancies 2010 ·The Prostate ·Mark N. Stein, Hongxia Lin, Chandrika Jeyamohan, Dmitri Dvorzhinski, Murugesan Gounder, Kevin Bray, Simantini Eddy, Susan Goodin, Eileen White, Robert S. DiPaola	238
20	Neutrophils Clear Bacteria Associated with Parasitic Nematodes Augmenting the Development of an Effective Th2-Type Response 2008 ·The Journal of Immunology ·John Pesce, Zhugong Liu, Hossein A. Hamed, Farhang Alem, J. Timothy Whitmire, Hongxia Lin, Qian Liu, Joseph F. Urban, William C. Gause	37

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact